MedSci Healthcare Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
27.00
66.00
-111.00
-177.00
37.00
21.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
18.00
-29.00
-40.00
-37.00
24.00
4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
59.00
42.00
-16.00
45.00
63.00
33.00
Cash Flow from Investing Activities
-343.00
-546.00
-2.00
-2.00
35.00
-34.00
Cash Flow from Financing Activities
-4.00
520.00
-8.00
344.00
104.00
-6.00
Net Cash Inflow / Outflow
-283.00
32.00
3.00
384.00
202.00
-7.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
5.00
16.00
31.00
-2.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of MedSci Healthcare Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
27.6444553123344
-530.534579061933
557.00
105.21%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
18.8936846794815
-207.857637070359
225.00
109.09%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
59.2821070366125
-195.09523822024
254.00
130.39%
Cash Flow from Investing Activities
-343.37369092114
77.163126647195
-420.00
-545.00%
Cash Flow from Financing Activities
-4.79552205539692
171.141480867791
-175.00
-102.80%
Net Cash Inflow / Outflow
-283.833538610012
53.6051109972596
-336.00
-629.49%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
5.05356732991296
0.395741702514102
5.00
1176.99%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 40.47% vs 358.45% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
59.28
42.20
40.47%






